Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A.
ETRA/EDNRA
TAT peptide
artificial transcription factor
cathepsin
cell-penetrating peptide
endosomal entrapment
protein transduction
zinc finger
Journal
Molecular therapy : the journal of the American Society of Gene Therapy
ISSN: 1525-0024
Titre abrégé: Mol Ther
Pays: United States
ID NLM: 100890581
Informations de publication
Date de publication:
02 02 2022
02 02 2022
Historique:
received:
07
09
2020
revised:
17
08
2021
accepted:
14
09
2021
pubmed:
22
9
2021
medline:
8
4
2022
entrez:
21
9
2021
Statut:
ppublish
Résumé
Cell-penetrating peptides (CPPs) hold great promise for intracellular delivery of therapeutic proteins. However, endosomal entrapment of transduced cargo is a major bottleneck hampering their successful application. While developing a transducible zinc finger protein-based artificial transcription factor targeting the expression of endothelin receptor A, we identified interaction between the CPP and the endosomal membrane or endosomal entanglement as a main culprit for endosomal entrapment. To achieve endosomal disentanglement, we utilized endosome-resident proteases to sever the artificial transcription factor from its CPP upon arrival inside the endosome. Using this approach, we greatly enhanced the correct subcellular localization of the disentangled artificial transcription factor, significantly increasing its biological activity and distribution in vivo. With rational engineering of proteolytic sensitivity, we propose a new design principle for transducible therapeutic proteins, helping CPPs attain their full potential as delivery vectors for therapeutic proteins.
Identifiants
pubmed: 34547467
pii: S1525-0016(21)00473-1
doi: 10.1016/j.ymthe.2021.09.018
pmc: PMC8821953
pii:
doi:
Substances chimiques
Cell-Penetrating Peptides
0
Receptors, Endothelin
0
Transcription Factors
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
855-867Informations de copyright
Copyright © 2021 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests This work was supported by contributions to A.N. from Aliophtha AG, Basel, Switzerland, under a research agreement with the University Hospital Basel. Aliophtha AG applied for patents with Aliophtha AG holding intellectual property rights.
Références
Nat Methods. 2013 Oct;10(10):973-6
pubmed: 23892895
Anal Biochem. 1997 Aug 1;250(2):181-5
pubmed: 9245437
Expert Opin Drug Deliv. 2015;12(10):1627-36
pubmed: 25994800
Nat Med. 2004 Mar;10(3):310-5
pubmed: 14770178
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21617-22
pubmed: 21106758
Nucleic Acids Res. 2009 Feb;37(2):e11
pubmed: 19050013
Biomed Res Int. 2017;2017:4816527
pubmed: 28904960
J Virol. 2005 Aug;79(15):9933-44
pubmed: 16014954
N Engl J Med. 2002 Mar 21;346(12):896-903
pubmed: 11907289
Drug Discov Today. 2019 Sep;24(9):1937-1942
pubmed: 31394173
Antibodies (Basel). 2020 May 20;9(2):
pubmed: 32443877
Cell. 1989 Jul 14;58(1):215-23
pubmed: 2752420
Front Cell Neurosci. 2015 Feb 02;9:16
pubmed: 25698929
Cell. 1984 Dec;39(3 Pt 2):499-509
pubmed: 6096007
Pharmacol Rev. 2016 Apr;68(2):357-418
pubmed: 26956245
Nat Protoc. 2010 Apr;5(4):791-810
pubmed: 20360772
Nat Rev Drug Discov. 2019 May;18(5):358-378
pubmed: 30710128
Glob Cardiol Sci Pract. 2014 Jun 18;2014(2):62-78
pubmed: 25405182
J Control Release. 2017 Jun 10;255:1-11
pubmed: 28385674
Trends Mol Med. 2007 Oct;13(10):443-8
pubmed: 17913584
J Control Release. 2007 Feb 12;117(2):148-62
pubmed: 17196289
J Control Release. 2005 Jan 20;102(1):247-53
pubmed: 15653149
Protein Expr Purif. 2006 Apr;46(2):483-8
pubmed: 16290005
J Biol Chem. 2003 Jan 3;278(1):585-90
pubmed: 12411431
Nature. 1997 May 1;387(6628):43-8
pubmed: 9139820
Mol Cell Biol. 1996 Oct;16(10):5772-81
pubmed: 8816491
Science. 2014 Jul 18;345(6194):1247125
pubmed: 25035496
Nat Rev Drug Discov. 2019 Jun;18(6):421-446
pubmed: 30846871
Genetics. 1989 May;122(1):19-27
pubmed: 2659436
BMC Genomics. 2008 Apr 02;9:152
pubmed: 18384671
Physiol Res. 2018 Jun 27;67(Suppl 1):S37-S54
pubmed: 29947527
EPMA J. 2017 Sep 13;8(4):327-332
pubmed: 29209435
FEBS Lett. 1999 Jan 22;443(1):48-52
pubmed: 9928950
Beilstein J Nanotechnol. 2020 Jan 9;11:101-123
pubmed: 31976201
Proc Natl Acad Sci U S A. 1978 Feb;75(2):901-4
pubmed: 273251
Biomed Pharmacother. 2018 Dec;108:1090-1096
pubmed: 30372809
Proc Natl Acad Sci U S A. 1998 Dec 8;95(25):14628-33
pubmed: 9843940
Front Cell Dev Biol. 2020 May 26;8:401
pubmed: 32528961
EPMA J. 2010 Jun;1(2):253-261
pubmed: 21258633
Biochem Pharmacol. 2020 Sep;179:114012
pubmed: 32389637